GNRH1 and polycystic ovary syndrome: <b>Methods:</b> This retrospective single-center study (2013-2024) analyzed 369 PCOS patients undergoing GnRH antagonist protocols who achieved optimal ovarian responses (10-20 oocytes with at least 40% of follicles ≥ 16 mm in diameter on trigger day).